New drug combo tested in fight against bone marrow cancer

NCT ID NCT06892522

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called etentamig, both alone and combined with other cancer medications, for people with multiple myeloma. It aims to find safe doses and see if these treatments can help control the cancer. About 440 adults with newly diagnosed or returning multiple myeloma will participate at sites worldwide.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atrium Health Levine Cancer Institute /ID# 276193
RECRUITING

Charlotte, North Carolina, 28204-2990, United States
Atrium Health Wake Forest Baptist Medical Center /ID# 274847
RECRUITING

Winston-Salem, North Carolina, 27157, United States
Coffs Harbour Health Campus /ID# 272010
RECRUITING

Coffs Harbour, New South Wales, 2450, Australia
Colorado Blood Cancer Institute /ID# 273129
RECRUITING

Denver, Colorado, 80218, United States
Hadassah Medical Center-Hebrew University /ID# 271362
RECRUITING

Jerusalem, 91120, Israel
Hammersmith Hospital /ID# 274615
RECRUITING

London, England, W12 0HS, United Kingdom
Icon Cancer Care - South Brisbane /ID# 271836
RECRUITING

South Brisbane, Queensland, 4101, Australia
Moffitt Cancer Center /ID# 272628
RECRUITING

Tampa, Florida, 33612, United States
Nagoya City University Hospital /ID# 273529
RECRUITING

Nagoya, Aichi-ken, 467-8602, Japan
Oncology Hematology Care - Kenwood /ID# 272918
RECRUITING

Cincinnati, Ohio, 45236, United States
Peter MacCallum Cancer Centre /ID# 272024
RECRUITING

Melbourne, Victoria, 3000, Australia
Port Macquarie Base Hospital /ID# 275925
RECRUITING

Port Macquarie, New South Wales, 2444, Australia
Rabin Medical Center. /ID# 271365
RECRUITING

Petah Tikva, 4941492, Israel
Rambam Health Care Campus- Haifa /ID# 271364
RECRUITING

Haifa, 3525408, Israel
Royal Adelaide Hospital /ID# 272629
RECRUITING

Adelaide, South Australia, 5000, Australia
Soroka Medical Center /ID# 271367
RECRUITING

Beersheba, Southern District, 8410101, Israel
St Vincent's Hospital - Melbourne /ID# 276451
RECRUITING

Fitzroy, Victoria, 3065, Australia
The Chaim Sheba Medical Center /ID# 271366
RECRUITING

Ramat Gan, Tel Aviv, 5265601, Israel
The Perth Blood Institute - West Perth /ID# 272469
RECRUITING

West Perth, Western Australia, 6005, Australia
The University of Osaka Hospital /ID# 275791
RECRUITING

Suita-shi, Osaka, 565-0871, Japan

Contact Phone: •••-•••-••••
University Hospital Kyoto Prefectural University of Medicine /ID# 275713
RECRUITING

Kyoto, Kyoto, 602-8566, Japan
University of North Carolina at Chapel Hill /ID# 274667
RECRUITING

Chapel Hill, North Carolina, 27514, United States
Weill Cornell Medical College /ID# 272517
RECRUITING

New York, New York, 10065, United States
Westmead Hospital /ID# 271880
RECRUITING

Westmead, New South Wales, 2145, Australia
Winship Cancer Institute of Emory University /ID# 274830
RECRUITING

Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA